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surgery, tricuspid valve surgery, redo surgery, left ventricu-
lar impairment, male gender, lower body mass index and
higher preoperative hemoglobin levels. Both a history of
diabetes and administration of aprotinin were associated
with reduced levels of chest tube drainage.
Conclusions: The individual operating surgeon was an inde-
pendent predictor of the extent of chest tube drainage. Atten-
tion to surgeon-speciﬁc factors offers the possibility of reduced
bleeding, fewer transfusions, and improved patient outcomes.
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Open access under CC BY-NC-ND license.EVERY YEAR an estimated 1 million to 1.25 million patientsworldwide undergo cardiac surgery. For these patients,
excessive bleeding into the chest remains a common and serious
complication. A large multicenter study of patients undergoing
high-risk surgery found 66% required a blood transfusion and 12%
had massive bleeding.1 Excessive bleeding results in increased
blood transfusions, higher redo-thoracotomy rates, prolonged
mechanical ventilation, prolonged intensive care, and hospital
stays, higher risk of death, and increased costs.2,3 A safe level of
bleeding has not been established, but the authors previously
reported that as little as 1,000 mL of chest tube drainage in the ﬁrst
24 hours was independently associated with a 4-fold higher risk of
death.2 The aim of the current study was to identify potentially
correctable factors associated with bleeding. Reduced bleeding
could lead to fewer blood transfusions and better clinical outcomes.METHODS
The study was undertaken at St. Vincent’s Hospital, Melbourne, a
large inner city tertiary university referral hospital in Melbourne,Australia. The authors analyzed data from 2,575 consecutive patients
who underwent cardiac surgery requiring cardiopulmonary bypass
between January 1, 2002 and February 12, 2008. Data were retrieved
from the patients’ electronic medical records (CareVue, Philips,
Eindhoven, Netherlands). Patients undergoing salvage surgery (under-
going cardiopulmonary resuscitation en route to the operating room,
n ¼ 7) and Jehovah’s Witness patients (n ¼ 17) were excluded.
This was a retrospective, observational, cohort study of patient data.
The St. Vincent’s Health Human Research Ethics Committee approved
the use of deidentiﬁed data for this study and waived the need for
individual patient consent. The anesthetic, surgical, and intensive care
management and associations between chest tube drainage and adverse
outcomes previously have been described.2
Chest tubes were placed just prior to sternal closure. Chest tube
drainage was recorded as the chest drain level at 24 hours following
admission to the intensive care unit (ICU). If the patient was discharged
from the ICU before 24 hours, the last recorded level was used.
Potentially life-threatening bleeding was deﬁned as41,000 mL of
chest tube drainage over 24 hours.2 Packed red blood cell transfusion
was deﬁned as administration of red cells in the 24 hours following
admission to the ICU. Type of surgery was classiﬁed as 1 of 3
categories: Coronary artery bypass grafting (CABG), valve surgery
(repair or replacement of valve), or complex surgery (multiple valve
surgery or coronary artery bypass grafting with valve surgery or
surgery involving the aortic arch). Urgency of surgery was classiﬁed
as 1 of 3 categories: Elective (the procedure could be deferred without
risk), urgent (surgery indicated within 72 hours of angiography or of
unplanned admission), and emergency (surgery required same day). Re-
do surgery was deﬁned by the patient having undergone cardiac surgery
on a previous admission.
In the ICU, packed red cells were transfused to maintain the
hemoglobin480 g/L. A combination of red cells, platelets, and plasma
products were considered for administration if chest tube losses
were4200 mL/hour for 2 consecutive hours. Redo-operation was
considered if the patient had sustained hemodynamic instability not
responding to intravenous ﬂuids with escalating requirement for
inotropic support in the setting of excessive chest bleeding (4400
mL over 1 hour) or evidence of cardiac tamponade on transthoracic
echocardiogram.
The outcome variable, chest tube drainage, was transformed to the
natural logarithmic scale to adjust for skewed results and to satisfy
model assumptions of normality and constant variance. A univariateracic and Vascular Anesthesia, Vol 28, No 2 (April), 2014: pp 242–246
Table 1. Patient and Surgical Characteristics
Characteristic
Value
(n ¼ 2,575)*
Age (y) 66  11
Male sex, n (%) 1,868 (73)
Hemoglobin (g/dL) 137  18
Creatinine (umol/L) 90 (80-110)
Hypertension, n (%) 1610 (63)
Diabetes, n (%) 691 (27)
Ever smoked, n (%) 2,137 (83)
Canadian Cardiovascular Society class 3 or 4 1,398 (54)
New York Heart Association class III or IV 1,242 (48)
Preoperative anticoagulation† 627 (24)
Left ventricle function‡, n (%)
Normal 810 (31)
Left ventricle hypertrophy 1053 (41)
Mild impairment 493 (19)
Moderate impairment 173 (7)
Severe impairment 46 (2)
Surgical urgency, n (%)
Elective 1,338 (52)
Urgent 1,029 (40)
Emergency 204 (8)
Surgery, n (%)
Redo 107 (4)
Single valve 274 (11)
Coronary artery bypass grafting 1,785 (69)
Complex§ 516 (20)
Aortic valve 553 (22)
Mitral valve 214 (8)
Tricuspid valve 34 (1)
Distal grafts
Total 3 (3-4)
Arterial 2 (1-3)
Internal mammary artery 1 (1-2)
Radial 1 (0-1)
Vein 1 (0-2)
Antiﬁbrinolytic, n (%)
Aprotinin 1,436 (58)
ε-aminocaproic acid 747 (30)
Tranexamic acid 301 (12)
Cardiopulmonary bypass time (min) 122  38
Hospital death, n (%) 60 (2.3)
Hospital stay (days) 7 (6-10)
NOTE. Data are presented as number (%) or median and (interquartile
range) or plus-minus, which denotes mean and standard deviation.
*Data for surgery urgency were missing for 4 patients, for anti-
ﬁbrinolytic for 93 patients, cardiopulmonary bypass time for 42
patients, and cross-clamp time for 59 patients.
†Preoperative anticoagulation was deﬁned as therapeutic levels of
anticoagulation by either a heparin infusion or subcutaneous enox-
aparin injections and which continued until the time of surgery.
‡Left ventricle function was based on preoperative echocardiogram or
angiographic assessment of the ejection fraction (normal450%, mild 35-
50%, moderate 20-34%, and severe impairmento20%). The deﬁnition of
left ventricular hypertrophy required a normal ejection fraction.
§Complex surgery was deﬁned as multiple valve surgery or
coronary artery bypass grafting with valve surgery or surgery invol-
ving the aortic arch.
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outcome variable, all effects estimated from the general linear model
are expressed as ratios of back-transformed medians with associated
95% conﬁdence intervals (data supplement). A general linear model
involving multiple explanatory variables was developed. Explanatory
variables were added to the model in 2 blocks. In block 1, known
predictors of bleeding (age, sex, type of surgery, redo surgery, urgency
of surgery, preoperative creatinine, and cardiopulmonary bypass time)
were ﬁtted in the model, and a backward elimination variable selection
method was used to remove nonstatistically signiﬁcant variables one at
a time.4–6 In block 2, the set of other potential predictors was
considered for inclusion into the model using a forward stepwise
procedure; the p-value for inclusion was 0.05. Variables considered
included body mass index, hemoglobin, left ventricle function,
preoperative anticoagulation, history of cardiovascular accident, acute
myocardial infarct, diabetes, hypertension or smoking, the Canadian
Cardiovascular Society Score, the New York Heart Association Score,
operating surgeon, antiﬁbrinolytic agent used, and type and number of
grafts.
RESULTS
The patient and surgical characteristics are summarized in
Table 1.
Patient factors associated with increased chest tube drainage
included male gender, a lower body mass index, impaired left
ventricular function, previous myocardial infarct, the Canadian
Cardiovascular score, the New York Heart Association score,
and higher preoperative hemoglobin levels. Preoperative ther-
apeutic anticoagulation was not associated with the extent of
chest tube drainage. A history of diabetes was associated with
reduced chest tube drainage (data supplement).
Surgical factors associated with increased chest tube drain-
age included the operating surgeon, total number of distal
internal mammary artery grafts, total number of distal radial
arterial grafts, increased cardiopulmonary bypass time, emer-
gency surgery, tricuspid valve surgery, and the extent of fall in
hemoglobin levels during surgery. The total number of vein
grafts was not associated with the extent of chest tube drainage.
Aprotinin administration and single valve surgery (other than
tricuspid) were both associated with reduced chest tube drain-
age (data supplement).
Five surgeons operated over the study period. The number
of cases per surgeon ranged from 282 to 846. On univariate
analysis, the mean chest tube drainage at 24 hours varied
signiﬁcantly among surgeons from 759 to 967 mL (p ¼ 0.006).
The percentage of patients with more than 1,000 mL of chest
tube drainage varied signiﬁcantly from 21 to 33% (p ¼ 0.001).
The volume of packed red blood cells transfused also varied
signiﬁcantly between surgeons from 145 to 420 mL
(po 0.0001). Redo-thoracotomy for acute cardiac tamponade
or uncontrolled bleeding did not vary signiﬁcantly among the
surgeons (1.4%-3.9% of patients, p ¼ 0.4) (Fig 1).
On multivariate analysis, patient factors independently asso-
ciated with increased chest tube drainage included male gender,
a lower body mass index, impaired left ventricular function, and
higher preoperative hemoglobin levels. A history of diabetes was
associated with reduced chest tube drainage (Table 2).
On multivariate analysis surgical factors independently
associated with increased chest tube drainage included operating
surgeon, left or right internal mammary artery grafts, increasedcardiopulmonary bypass time, tricuspid valve surgery, redo
surgery, and emergency surgery. Aprotinin was associated with
reduced chest tube drainage (Table 2).
Fig 1. Variation among surgeons in bleeding complications
(unadjusted). Chest tube drainage in the ﬁrst 24 hours (p ¼ 0.006),
chest tube drainage41,000 mL (p ¼ 0.001), packed red cells
transfused in the ﬁrst 24 hours (p o 0.0001), and redo-thoracotomy
for acute cardiac tamponade or uncontrolled bleeding (p ¼ 0.4).
Statistical tests more one way ANOVA or chi-square. Graphs with
error bars represent mean and standard error.
Table 2. Characteristics Independently Associated With
Chest Tube Drainage
Characteristic
Ratio of median chest tube
drainage (95% CI) p value
Operating surgeon 0.006
Gender (Male vs. Female) 1.15 (1.09, 1.20) o0.001
Body mass index (per 1 kg/m2
decrease)
1.02 (1.01, 1.02) o0.001
Preoperative hemoglobin (per 10
g/L increase)
1.03 (1.02, 1.05) o0.001
Left ventricle function* 0.01
Severe impairment v normal 1.27 (1.05, 1.49)
Severe impairment v mild
impairment
1.22 (1.02, 1.45)
Severe impairment v moderate
impairment
1.10 (0.91, 1.32)
Severe impairment v left
ventricle hypertrophy
1.23 (1.02, 1.47)
Diabetes (Yes v No) 0.91 (0.87, 0.96) 0.001
Tricuspid valve surgery (Yes v No) 1.50 (1.23, 1.84) o0.001
Right internal mammary artery
(Yes v No)
1.34 (1.27, 1.41) o0.001
Left internal mammary artery (Yes
v No)
1.22 (1.15, 1.29) o0.001
Redo surgery (Yes v No) 1.20 (1.07, 1.36) 0.003
Cardiopulmonary bypass time
(per 10-minute increase)
1.03 (1.02, 1.03) o0.001
Surgery urgency 0.001
Emergency v elective 1.17 (1.07, 1.27)
Emergency v urgent 1.18 (1.08, 1.29)
Urgent v elective 0.99 (0.94, 1.04)
Antiﬁbrinolytic o0.001
Tranexamic acid v aprotinin 1.29 (1.20, 1.39)
ε-aminocaproic acid v aprotinin 1.25 (1.18, 1.31)
Tranexamic acid v
ε-aminocaproic acid
1.04 (0.96, 1.12)
* Left ventricle function based on preoperative echocardiogram or
angiographic assessment of the ejection fraction (normal450%, mild
35-50%, moderate 20-34%, and severe impairment o20%). The deﬁ-
nition of left ventricular hypertrophy required a normal ejection
fraction.
DIXON ET AL244DISCUSSION
The authors investigated predictors of bleeding following
cardiac surgery to identify potentially correctable factors. Their
major ﬁnding was that the individual operating surgeon was an
independent predictor. Their results suggested that surgeon-
speciﬁc factors may contribute to the extent of bleeding.Addressing surgeon-speciﬁc factors offers the possibility of
reduced bleeding, fewer transfusions, and improved patient
outcomes.
While many studies have documented the risk factors
associated with bleeding and blood transfusions following
cardiac surgery, the authors are aware of only 2 that have
considered the role of the individual operating surgeon.7,8
These studies found the extent of bleeding, blood transfusions,
and re-exploration varied signiﬁcantly among surgeons under-
taking similar cases, with up to 9-fold differences. An audit of
798 surgical units in the United States found the percentage of
patients requiring a blood transfusion ranged from 8% to 93%.
This variation could not be explained on the basis of patient or
other hospital factors.9 These ﬁndings suggest that variations in
surgeons’ hemostatic practices may be an important factor
contributing to the extent of bleeding complications. This
conclusion is supported by studies in Jehovah’s Witness
patients that found chest tube drainage levels were 50%
lower compared with routine cases.10–13 These results
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meticulous hemostatic practices, but perhaps, more impor-
tantly, suggest that surgeons’ hemostatic practices may be less
meticulous when blood transfusion is an option. Bleeding after
cardiac surgery, however, contributes to adverse outcomes not
only through blood loss but also through the accumulation of
blood within the chest. Chest drains are inefﬁcient at draining
blood from the chest and even modest levels of retained blood
can cause both acute and subacute forms of cardiac tamponade
and hemothorax with respiratory dysfunction.2,3,14–17
It may be argued that the signiﬁcant variation the authors
found among surgeons in the average chest tube drainage at 24
hours (208 mL) was unlikely to be of any clinical signiﬁcance.
A range of evidence, however, indicates even relatively modest
increases in chest tube drainage may be harmful. The authors
previously have demonstrated that the level of chest tube
drainage has an exponential relationship with the risk of death,
and as little as 1,000 mL of drainage at 24 hours was associated
with a 4-fold higher risk of death.2 Using this endpoint, the
authors found marked variation (21%-33%) in the proportion of
patients with potentially life-threatening bleeding. Furthermore,
chest drains are inefﬁcient, and the volume of drainage
recorded may underestimate the true blood loss. This may
explain the larger variations found in blood transfusion levels
and re-thoracotomy rates among the surgeons ( threefold
variations). Finally, it is estimated that cardiac surgery patients
consume around 20% of the worldwide blood supply; on this
basis, even modest reductions in bleeding could have profound
effects on the demand for blood products.18 The authors
calculate a reduction in chest tube drainage of 200 mL would
result in 50 fewer units of packed red blood cells transfused per
100 patients.
Monitoring adverse outcomes following cardiac surgery is
important to maintain and improve patient outcomes. Both The
Great Britain and Ireland National Adult Cardiac Surgical
Database and The American Society for Thoracic Surgeons
(STS) National Adult Cardiac Surgical Database monitor blood
transfusion and reoperation rates for bleeding or cardiac
tamponade but do not monitor chest tube drainage levels.19
The authors believe measurement of chest tube drainage
provides the best method to monitor excessive bleeding. It is
relatively objective, already is performed routinely, and has
been shown to be highly correlated with blood transfusion
volumes and also a strong independent predictor of death.2
The authors found other factors also were independently
associated with the extent of chest tube drainage. These
additional factors had, however, less potential for correction.
Patient factors included male sex, lower body mass index, left
ventricular impairment, and higher baseline hemoglobin levels,
whereas a history of diabetes was associated with reduced chest
drainage. The authors speculate that increased clotting activity
associated with female sex, diabetes, and obesity may play a
role in reduced bleeding.20 With regard to left ventricular or
tricuspid impairment, it is plausible that clotting may be
impaired through liver congestion. Furthermore, the operation
may be technically more challenging due to the severity of
heart disease and poor tissue integrity. The association between
higher baseline hemoglobin levels and increased chest tubedrainage was surprising, and an explanation is not obvious. The
authors found no association between baseline creatinine levels
and chest tube drainage. This ﬁnding is inconsistent with an
earlier study.6
Surgical factors independently associated with the extent of
chest tube drainage included harvesting of left or right internal
mammary arteries, as has been documented previously.21
Interestingly, the number of venous grafts was not a factor
suggesting the increased risk may relate to bleeding associated
with dissection of the internal mammary arteries from the chest
wall. Increased cardiopulmonary bypass time was also a risk
factor.3 This association may reﬂect a more complex operation
or the development of more profound coagulopathic or
ﬁbrinolytic states.22 Other associations, including redo surgery
and emergency surgery, have an empirical sense on the basis of
increased surgical complexity and greater patient morbidity. As
with previous studies, the antiﬁbrinolytic aprotinin reduced
chest tube drainage compared with the lysine analogs.23
Aprotinin has, however, been withdrawn from routine clinical
use. Preoperative therapeutic anticoagulation was not associ-
ated with increased chest tube drainage, as has been demon-
strated by an earlier study.24 The routine administration of high
doses of heparin to all patients during surgery may explain this
ﬁnding.
The authors’ study had a number of strengths. First, they
adjusted for multiple patient and surgical factors known to
inﬂuence chest tube drainage. Second, the characteristics of the
patients were typical of contemporary practices, and the extent
of chest tube drainage was similar to published data from well-
established units both in the United States and Europe.25,26 The
authors chose the chest drain level at 24 hours after intensive
care admission to enable comparisons with previous studies.
A potential drawback of the 24-hour time point is that it
underestimates the extent of chest tube drainage in patients
discharged from the intensive care before 24 hours. The
patients included in this analysis were operated on between
2002 and 2008. Some surgical practices have evolved since
that time, with increased use of off-pump techniques and
implantation of sutureless valves. These changes may inﬂuence
the generalizability of the authors’ results. Their study design
did not allow them to determine the cause of the associations
with chest tube drainage that was found. They have speculated
that variations in surgeons’ hemostatic practices may play a
role; it is, however, possible that other surgeon-speciﬁc factors,
such as the other members of the operating team (the per-
fusionist or anesthesiologist) could also inﬂuence chest tube
drainage. Furthermore, the authors cannot exclude the possi-
bility that other patient and surgical confounding factors may
have existed, which, if adjusted for, may have eliminated the
association found between surgeon and the extent of chest tube
drainage.CONCLUSIONS
The operating surgeon was an independent predictor of the
extent of chest tube drainage. Attention to surgeon-speciﬁc
factors offers the possibility of reduced bleeding, fewer trans-
fusions, and improved patient outcomes.
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